{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:37:52Z","timestamp":1794638272685,"version":"4.9.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL147545"],"award-info":[{"award-number":["R01HL147545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA33572"],"award-info":[{"award-number":["P30CA33572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK012170"],"award-info":[{"award-number":["R01DK012170"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK100425"],"award-info":[{"award-number":["R01DK100425"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK118011"],"award-info":[{"award-number":["R01DK118011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK136671"],"award-info":[{"award-number":["R01DK136671"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK134675"],"award-info":[{"award-number":["R01DK134675"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alfred E. Mann Family Foundation Arthur Riggs Diabetes and Metabolism Research Institute"},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["11-22-JDFPM-06"],"award-info":[{"award-number":["11-22-JDFPM-06"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-025-01399-3","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:02:33Z","timestamp":1763114553000},"page":"2284-2299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-0953","authenticated-orcid":false,"given":"Vinod","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byungchang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4011-0750","authenticated-orcid":false,"given":"Olivia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin D. J.","family":"Lopez Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8408-5686","authenticated-orcid":false,"given":"Hardik","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6979-103X","authenticated-orcid":false,"given":"Mark A.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-7182","authenticated-orcid":false,"given":"Cassandra N.","family":"Spracklen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3881-7895","authenticated-orcid":false,"given":"Russell P.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4955-3226","authenticated-orcid":false,"given":"Charles","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"1399_CR1","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1093\/emboj\/20.18.5060","volume":"20","author":"L Palmieri","year":"2001","unstructured":"Palmieri, L. et al. Citrin and aralar1 are Ca2+-stimulated aspartate\/glutamate transporters in mitochondria. EMBO J. 20, 5060\u20135069 (2001).","journal-title":"EMBO J."},{"key":"1399_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s100380200046","volume":"47","author":"T Saheki","year":"2002","unstructured":"Saheki, T. & Kobayashi, K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J. Hum. Genet. 47, 333\u2013341 (2002).","journal-title":"J. Hum. Genet."},{"key":"1399_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.hepres.2005.09.031","volume":"33","author":"T Saheki","year":"2005","unstructured":"Saheki, T. et al. Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Hepatol. Res. 33, 181\u2013184 (2005).","journal-title":"Hepatol. Res."},{"key":"1399_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/s12887-020-02409-x","volume":"20","author":"SC Grunert","year":"2020","unstructured":"Grunert, S. C. et al. Citrin deficiency mimicking mitochondrial depletion syndrome. BMC Pediatr. 20, 518 (2020).","journal-title":"BMC Pediatr."},{"key":"1399_CR5","doi-asserted-by":"publisher","unstructured":"Saheki, T., Moriyama, M., Funahashi, A. & Kuroda, E. AGC2 (citrin) deficiency\u2014from recognition of the disease till construction of therapeutic procedures. Biomolecules https:\/\/doi.org\/10.3390\/biom10081100 (2020).","DOI":"10.3390\/biom10081100"},{"key":"1399_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jimd.12206","volume":"43","author":"Y Lin","year":"2020","unstructured":"Lin, Y. et al. Combining newborn metabolic and genetic screening for neonatal intrahepatic cholestasis caused by citrin deficiency. J. Inherit. Metab. Dis. 43, 467\u2013477 (2020).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1399_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ymgme.2011.12.024","volume":"105","author":"A Kikuchi","year":"2012","unstructured":"Kikuchi, A. et al. Simple and rapid genetic testing for citrin deficiency by screening 11 prevalent mutations in SLC25A13. Mol. Genet. Metab. 105, 553\u2013558 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"1399_CR8","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/jimd.12722","volume":"47","author":"J Kido","year":"2024","unstructured":"Kido, J., Makris, G., Santra, S. & Haberle, J. Clinical landscape of citrin deficiency: a global perspective on a multifaceted condition. J. Inherit. Metab. Dis. 47, 1144\u20131156 (2024).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1399_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3345\/cep.2020.00059","volume":"63","author":"SY Kim","year":"2020","unstructured":"Kim, S. Y. & Yi, D. Y. Components of human breast milk: from macronutrient to microbiome and microRNA. Clin. Exp. Pediatr. 63, 301\u2013309 (2020).","journal-title":"Clin. Exp. Pediatr."},{"key":"1399_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","volume":"32","author":"P Belenky","year":"2007","unstructured":"Belenky, P., Bogan, K. L. & Brenner, C. NAD+ metabolism in health and disease. Trends Biochem. Sci. 32, 12\u201319 (2007).","journal-title":"Trends Biochem. Sci."},{"key":"1399_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1126\/science.1218099","volume":"337","author":"DK Bricker","year":"2012","unstructured":"Bricker, D. K. et al. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337, 96\u2013100 (2012).","journal-title":"Science"},{"key":"1399_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202256596","volume":"24","author":"S Goyal","year":"2023","unstructured":"Goyal, S. et al. Dynamics of SLC25A51 reveal preference for oxidized NAD+ and substrate led transport. EMBO Rep. 24, e56596 (2023).","journal-title":"EMBO Rep."},{"key":"1399_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0968-0004(79)90417-1","volume":"4","author":"AG Dawson","year":"1979","unstructured":"Dawson, A. G. Oxidation of cytosolic NADH formed during aerobic metabolism in mammalian cells. Trends Biochem. Sci. 4, 171\u2013176 (1979).","journal-title":"Trends Biochem. Sci."},{"key":"1399_CR14","doi-asserted-by":"publisher","first-page":"25041","DOI":"10.1074\/jbc.M702031200","volume":"282","author":"T Saheki","year":"2007","unstructured":"Saheki, T. et al. Citrin\/mitochondrial glycerol-3-phosphate dehydrogenase double knock-out mice recapitulate features of human citrin deficiency. J. Biol. Chem. 282, 25041\u201325052 (2007).","journal-title":"J. Biol. Chem."},{"key":"1399_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.tem.2022.05.002","volume":"33","author":"S Tavoulari","year":"2022","unstructured":"Tavoulari, S., Lacabanne, D., Thangaratnarajah, C. & Kunji, E. R. S. Pathogenic variants of the mitochondrial aspartate\/glutamate carrier causing citrin deficiency. Trends Endocrinol. Metab. 33, 539\u2013553 (2022).","journal-title":"Trends Endocrinol. Metab."},{"key":"1399_CR16","volume":"35","author":"L Gonzalez-Moreno","year":"2023","unstructured":"Gonzalez-Moreno, L. et al. Exogenous aralar\/slc25a12 can replace citrin\/slc25a13 as malate aspartate shuttle component in liver. Mol. Genet. Metab. Rep. 35, 100967 (2023).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"1399_CR17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s10545-008-0752-x","volume":"31","author":"T Saheki","year":"2008","unstructured":"Saheki, T. et al. Reduced carbohydrate intake in citrin-deficient subjects. J. Inherit. Metab. Dis. 31, 386\u2013394 (2008).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1399_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jhep.2008.05.016","volume":"49","author":"M Komatsu","year":"2008","unstructured":"Komatsu, M. et al. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. J. Hepatol. 49, 810\u2013820 (2008).","journal-title":"J. Hepatol."},{"key":"1399_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2169\/internalmedicine.49.2712","volume":"49","author":"K Fukushima","year":"2010","unstructured":"Fukushima, K. et al. Conventional diet therapy for hyperammonemia is risky in the treatment of hepatic encephalopathy associated with citrin deficiency. Intern. Med. 49, 243\u2013247 (2010).","journal-title":"Intern. Med."},{"key":"1399_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1128\/MCB.24.2.527-536.2004","volume":"24","author":"DS Sinasac","year":"2004","unstructured":"Sinasac, D. S. et al. Slc25a13-knockout mice harbor metabolic deficits but fail to display hallmarks of adult-onset type II citrullinemia. Mol. Cell. Biol. 24, 527\u2013536 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"1399_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ymgme.2017.02.004","volume":"120","author":"T Saheki","year":"2017","unstructured":"Saheki, T. et al. Oral aversion to dietary sugar, ethanol and glycerol correlates with alterations in specific hepatic metabolites in a mouse model of human citrin deficiency. Mol. Genet. Metab. 120, 306\u2013316 (2017).","journal-title":"Mol. Genet. Metab."},{"key":"1399_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s42255-021-00354-2","volume":"3","author":"KH Flippo","year":"2021","unstructured":"Flippo, K. H. & Potthoff, M. J. Metabolic messengers: FGF21. Nat. Metab. 3, 309\u2013317 (2021).","journal-title":"Nat. Metab."},{"key":"1399_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cmet.2020.06.008","volume":"32","author":"SO Jensen-Cody","year":"2020","unstructured":"Jensen-Cody, S. O. et al. FGF21 signals to glutamatergic neurons in the ventromedial hypothalamus to suppress carbohydrate intake. Cell Metab. 32, 273\u2013286 e276 (2020).","journal-title":"Cell Metab."},{"key":"1399_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cmet.2021.12.024","volume":"34","author":"KH Flippo","year":"2022","unstructured":"Flippo, K. H. et al. FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit. Cell Metab. 34, 317\u2013328 e316 (2022).","journal-title":"Cell Metab."},{"key":"1399_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu, J. et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250\u2013259 (2009).","journal-title":"Diabetes"},{"key":"1399_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101324","volume":"53","author":"P Zouhar","year":"2021","unstructured":"Zouhar, P. et al. A pyrexic effect of FGF21 independent of energy expenditure and UCP1. Mol. Metab. 53, 101324 (2021).","journal-title":"Mol. Metab."},{"key":"1399_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki, T. et al. Endocrine regulation of the fasting response by PPAR\u03b1-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415\u2013425 (2007).","journal-title":"Cell Metab."},{"key":"1399_CR28","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.1073\/pnas.0904187106","volume":"106","author":"MJ Potthoff","year":"2009","unstructured":"Potthoff, M. J. et al. FGF21 induces PGC-1\u03b1 and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl Acad. Sci. USA 106, 10853\u201310858 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1399_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","volume":"5","author":"MK Badman","year":"2007","unstructured":"Badman, M. K. et al. Hepatic fibroblast growth factor 21 is regulated by PPAR\u03b1 and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426\u2013437 (2007).","journal-title":"Cell Metab."},{"key":"1399_CR30","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","volume":"94","author":"BM Forman","year":"1997","unstructured":"Forman, B. M., Chen, J. & Evans, R. M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors \u03b1 and \u03b4. Proc. Natl Acad. Sci. USA 94, 4312\u20134317 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1399_CR31","doi-asserted-by":"publisher","first-page":"e22976","DOI":"10.1371\/journal.pone.0022976","volume":"6","author":"T Uebanso","year":"2011","unstructured":"Uebanso, T. et al. Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor? PLoS ONE 6, e22976 (2011).","journal-title":"PLoS ONE"},{"key":"1399_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cmet.2017.04.009","volume":"25","author":"S Soberg","year":"2017","unstructured":"Soberg, S. et al. FGF21 is a sugar-induced hormone associated with sweet intake and preference in humans. Cell Metab. 25, 1045\u20131053 e1046 (2017).","journal-title":"Cell Metab."},{"key":"1399_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cmet.2015.12.003","volume":"23","author":"S von Holstein-Rathlou","year":"2016","unstructured":"von Holstein-Rathlou, S. et al. FGF21 mediates endocrine control of simple sugar intake and sweet taste preference by the liver. Cell Metab. 23, 335\u2013343 (2016).","journal-title":"Cell Metab."},{"key":"1399_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.celrep.2017.09.065","volume":"21","author":"A Iroz","year":"2017","unstructured":"Iroz, A. et al. A specific ChREBP and PPAR\u03b1 cross-talk is required for the glucose-mediated FGF21 response. Cell Rep. 21, 403\u2013416 (2017).","journal-title":"Cell Rep."},{"key":"1399_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.molmet.2014.09.008","volume":"4","author":"JR Dushay","year":"2015","unstructured":"Dushay, J. R. et al. Fructose ingestion acutely stimulates circulating FGF21 levels in humans. Mol. Metab. 4, 51\u201357 (2015).","journal-title":"Mol. Metab."},{"key":"1399_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.molmet.2016.11.008","volume":"6","author":"FM Fisher","year":"2017","unstructured":"Fisher, F. M. et al. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. Mol. Metab. 6, 14\u201321 (2017).","journal-title":"Mol. Metab."},{"key":"1399_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","volume":"8","author":"C Galman","year":"2008","unstructured":"Galman, C. et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPAR\u03b1 activation in man. Cell Metab. 8, 169\u2013174 (2008).","journal-title":"Cell Metab."},{"key":"1399_CR38","doi-asserted-by":"publisher","first-page":"e63517","DOI":"10.1371\/journal.pone.0063517","volume":"8","author":"KH Kim","year":"2013","unstructured":"Kim, K. H. et al. Acute exercise induces FGF21 expression in mice and in healthy humans. PLoS ONE 8, e63517 (2013).","journal-title":"PLoS ONE"},{"key":"1399_CR39","doi-asserted-by":"publisher","first-page":"e38022","DOI":"10.1371\/journal.pone.0038022","volume":"7","author":"D Cuevas-Ramos","year":"2012","unstructured":"Cuevas-Ramos, D. et al. Exercise increases serum fibroblast growth factor 21 (FGF21) levels. PLoS ONE 7, e38022 (2012).","journal-title":"PLoS ONE"},{"key":"1399_CR40","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.2337\/db14-0595","volume":"63","author":"KR Markan","year":"2014","unstructured":"Markan, K. R. et al. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes 63, 4057\u20134063 (2014).","journal-title":"Diabetes"},{"key":"1399_CR41","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/db07-1476","volume":"57","author":"X Zhang","year":"2008","unstructured":"Zhang, X. et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57, 1246\u20131253 (2008).","journal-title":"Diabetes"},{"key":"1399_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/s-2007-985148","volume":"116","author":"WW Chen","year":"2008","unstructured":"Chen, W. W. et al. Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 116, 65\u201368 (2008).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"1399_CR43","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/hmg\/ddq310","volume":"19","author":"H Tyynismaa","year":"2010","unstructured":"Tyynismaa, H. et al. Mitochondrial myopathy induces a starvation-like response. Hum. Mol. Genet. 19, 3948\u20133958 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"1399_CR44","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2337\/db16-1384","volume":"66","author":"CYY Cheung","year":"2017","unstructured":"Cheung, C. Y. Y. et al. An exome-chip association analysis in Chinese subjects reveals a functional missense variant of GCKR that regulates FGF21 levels. Diabetes 66, 1723\u20131728 (2017).","journal-title":"Diabetes"},{"key":"1399_CR45","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.molmet.2017.08.004","volume":"6","author":"BN Desai","year":"2017","unstructured":"Desai, B. N. et al. Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury. Mol. Metab. 6, 1395\u20131406 (2017).","journal-title":"Mol. Metab."},{"key":"1399_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-020-2337-2","volume":"583","author":"RP Goodman","year":"2020","unstructured":"Goodman, R. P. et al. Hepatic NADH reductive stress underlies common variation in metabolic traits. Nature 583, 122\u2013126 (2020).","journal-title":"Nature"},{"key":"1399_CR47","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1172\/JCI74915","volume":"124","author":"T Laeger","year":"2014","unstructured":"Laeger, T. et al. FGF21 is an endocrine signal of protein restriction. J. Clin. Invest. 124, 3913\u20133922 (2014).","journal-title":"J. Clin. Invest."},{"key":"1399_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100623","volume":"296","author":"LS Katz","year":"2021","unstructured":"Katz, L. S., Baumel-Alterzon, S., Scott, D. K. & Herman, M. A. Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets. J. Biol. Chem. 296, 100623 (2021).","journal-title":"J. Biol. Chem."},{"key":"1399_CR49","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cmet.2017.07.004","volume":"26","author":"A Abdul-Wahed","year":"2017","unstructured":"Abdul-Wahed, A., Guilmeau, S. & Postic, C. Sweet sixteenth for ChREBP: established roles and future goals. Cell Metab. 26, 324\u2013341 (2017).","journal-title":"Cell Metab."},{"key":"1399_CR50","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1074\/jbc.M107895200","volume":"277","author":"T Kawaguchi","year":"2002","unstructured":"Kawaguchi, T., Osatomi, K., Yamashita, H., Kabashima, T. & Uyeda, K. Mechanism for fatty acid \u201csparing\u201d effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J. Biol. Chem. 277, 3829\u20133835 (2002).","journal-title":"J. Biol. Chem."},{"key":"1399_CR51","doi-asserted-by":"publisher","first-page":"28721","DOI":"10.1074\/jbc.M601576200","volume":"281","author":"L Ma","year":"2006","unstructured":"Ma, L., Robinson, L. N. & Towle, H. C. ChREBP\u2022Mlx is the principal mediator of glucose-induced gene expression in the liver. J. Biol. Chem. 281, 28721\u201328730 (2006).","journal-title":"J. Biol. Chem."},{"key":"1399_CR52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature10986","volume":"484","author":"MA Herman","year":"2012","unstructured":"Herman, M. A. et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 484, 333\u2013338 (2012).","journal-title":"Nature"},{"key":"1399_CR53","doi-asserted-by":"publisher","first-page":"21991","DOI":"10.1074\/jbc.270.37.21991","volume":"270","author":"HM Shih","year":"1995","unstructured":"Shih, H. M., Liu, Z. & Towle, H. C. Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription. J. Biol. Chem. 270, 21991\u201321997 (1995).","journal-title":"J. Biol. Chem."},{"key":"1399_CR54","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.2337\/db05-0822","volume":"55","author":"MV Li","year":"2006","unstructured":"Li, M. V., Chang, B., Imamura, M., Poungvarin, N. & Chan, L. Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. Diabetes 55, 1179\u20131189 (2006).","journal-title":"Diabetes"},{"key":"1399_CR55","doi-asserted-by":"publisher","first-page":"e34803","DOI":"10.1371\/journal.pone.0034803","volume":"7","author":"LG McFerrin","year":"2012","unstructured":"McFerrin, L. G. & Atchley, W. R. A novel N-terminal domain may dictate the glucose response of Mondo proteins. PLoS ONE 7, e34803 (2012).","journal-title":"PLoS ONE"},{"key":"1399_CR56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bbrc.2010.04.028","volume":"395","author":"MV Li","year":"2010","unstructured":"Li, M. V. et al. Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem. Biophys. Res. Commun. 395, 395\u2013400 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1399_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1042\/BJ20111280","volume":"443","author":"C Arden","year":"2012","unstructured":"Arden, C. et al. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. Biochem. J. 443, 111\u2013123 (2012).","journal-title":"Biochem. J."},{"key":"1399_CR58","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1073\/pnas.0730817100","volume":"100","author":"T Kabashima","year":"2003","unstructured":"Kabashima, T., Kawaguchi, T., Wadzinski, B. E. & Uyeda, K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc. Natl Acad. Sci. USA 100, 5107\u20135112 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1399_CR59","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1172\/JCI81993","volume":"126","author":"MS Kim","year":"2016","unstructured":"Kim, M. S. et al. ChREBP regulates fructose-induced glucose production independently of insulin signaling. J. Clin. Invest. 126, 4372\u20134386 (2016).","journal-title":"J. Clin. Invest."},{"key":"1399_CR60","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cmet.2023.11.010","volume":"36","author":"C Singh","year":"2024","unstructured":"Singh, C. et al. ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits. Cell Metab. 36, 144\u2013158 (2024).","journal-title":"Cell Metab."},{"key":"1399_CR61","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1101\/pdb.top084970","volume":"2015","author":"KR Kukurba","year":"2015","unstructured":"Kukurba, K. R. & Montgomery, S. B. RNA sequencing and analysis. Cold Spring Harb. Protoc. 2015, 951\u2013969 (2015).","journal-title":"Cold Spring Harb. Protoc."},{"key":"1399_CR62","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1194\/jlr.M081836","volume":"59","author":"AG Linden","year":"2018","unstructured":"Linden, A. G. et al. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. J. Lipid Res. 59, 475\u2013487 (2018).","journal-title":"J. Lipid Res."},{"key":"1399_CR63","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinf. 12, 323 (2011).","journal-title":"BMC Bioinf."},{"key":"1399_CR64","doi-asserted-by":"publisher","first-page":"41914","DOI":"10.1074\/jbc.M112.418855","volume":"287","author":"Q Ge","year":"2012","unstructured":"Ge, Q. et al. Structural characterization of a unique interface between carbohydrate response element-binding protein (ChREBP) and 14-3-3beta protein. J. Biol. Chem. 287, 41914\u201341921 (2012).","journal-title":"J. Biol. Chem."},{"key":"1399_CR65","doi-asserted-by":"publisher","first-page":"6912","DOI":"10.1073\/pnas.0712199105","volume":"105","author":"CA Stoltzman","year":"2008","unstructured":"Stoltzman, C. A. et al. Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression. Proc. Natl Acad. Sci. USA 105, 6912\u20136917 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1399_CR66","doi-asserted-by":"publisher","unstructured":"Velazquez-Campoy, A., Ohtaka, H., Nezami, A., Muzammil, S. & Freire, E. Isothermal titration calorimetry. Curr. Protoc. Cell Biol. https:\/\/doi.org\/10.1002\/0471143030.cb1708s23 (2004).","DOI":"10.1002\/0471143030.cb1708s23"},{"key":"1399_CR67","doi-asserted-by":"publisher","unstructured":"Tiwari, V. et al. Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.12.27.630525 (2025).","DOI":"10.1101\/2024.12.27.630525"},{"key":"1399_CR68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2505263122","volume":"122","author":"MC Cheong","year":"2025","unstructured":"Cheong, M. C. et al. Ethanol induction of FGF21 in the liver is dependent on histone acetylation and ligand activation of ChREBP by glycerol-3-phosphate. Proc. Natl Acad. Sci. USA 122, e2505263122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1399_CR69","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","volume":"1","author":"PJ Randle","year":"1963","unstructured":"Randle, P. J., Garland, P. B., Hales, C. N. & Newsholme, E. A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785\u2013789 (1963).","journal-title":"Lancet"},{"key":"1399_CR70","first-page":"934","volume":"20","author":"EP Kennedy","year":"1961","unstructured":"Kennedy, E. P. Biosynthesis of complex lipids. Fed. Proc. 20, 934\u2013940 (1961).","journal-title":"Fed. Proc."},{"key":"1399_CR71","doi-asserted-by":"publisher","first-page":"E578","DOI":"10.1152\/ajpendo.00093.2009","volume":"297","author":"L Hue","year":"2009","unstructured":"Hue, L. & Taegtmeyer, H. The Randle cycle revisited: a new head for an old hat. Am. J. Physiol. Endocrinol. Metab. 297, E578\u2013E591 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1399_CR72","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1016\/S0021-9258(17)34693-8","volume":"253","author":"JD McGarry","year":"1978","unstructured":"McGarry, J. D., Leatherman, G. F. & Foster, D. W. Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J. Biol. Chem. 253, 4128\u20134136 (1978).","journal-title":"J. Biol. Chem."},{"key":"1399_CR73","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","volume":"61","author":"S Softic","year":"2016","unstructured":"Softic, S., Cohen, D. E. & Kahn, C. R. Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Dig. Dis. Sci. 61, 1282\u20131293 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"1399_CR74","doi-asserted-by":"publisher","unstructured":"Ouyang, S. et al. Glycerol kinase drives hepatic de novo lipogenesis and triglyceride synthesis in nonalcoholic fatty liver by activating SREBP-1c transcription, upregulating DGAT1\/2 expression, and promoting glycerol metabolism. Adv. Sci.https:\/\/doi.org\/10.1002\/advs.202401311 (2024).","DOI":"10.1002\/advs.202401311"},{"key":"1399_CR75","doi-asserted-by":"publisher","unstructured":"Costa-Mattioli, M. & Walter, P. The integrated stress response: from mechanism to disease. Science https:\/\/doi.org\/10.1126\/science.aat5314 (2020).","DOI":"10.1126\/science.aat5314"},{"key":"1399_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102068","volume":"91","author":"MSH Khan","year":"2024","unstructured":"Khan, M. S. H. et al. FGF21 acts in the brain to drive macronutrient-specific changes in behavioral motivation and brain reward signaling. Mol. Metab. 91, 102068 (2024).","journal-title":"Mol. Metab."},{"key":"1399_CR77","doi-asserted-by":"publisher","first-page":"9700","DOI":"10.1074\/jbc.M115.704254","volume":"291","author":"LR de la Ballina","year":"2016","unstructured":"de la Ballina, L. R. et al. Amino acid transport associated to cluster of differentiation 98 heavy chain (CD98hc) is at the cross-road of oxidative stress and amino acid availability. J. Biol. Chem. 291, 9700\u20139711 (2016).","journal-title":"J. Biol. Chem."},{"key":"1399_CR78","doi-asserted-by":"publisher","first-page":"19952","DOI":"10.1074\/jbc.R117.819060","volume":"292","author":"CL Lomelino","year":"2017","unstructured":"Lomelino, C. L., Andring, J. T., McKenna, R. & Kilberg, M. S. Asparagine synthetase: function, structure, and role in disease. J. Biol. Chem. 292, 19952\u201319958 (2017).","journal-title":"J. Biol. Chem."},{"key":"1399_CR79","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ymgme.2009.04.001","volume":"97","author":"JP Kraus","year":"2009","unstructured":"Kraus, J. P. et al. Cystathionine \u03b3-lyase: clinical, metabolic, genetic, and structural studies. Mol. Genet. Metab. 97, 250\u2013259 (2009).","journal-title":"Mol. Genet. Metab."},{"key":"1399_CR80","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmet.2016.01.019","volume":"23","author":"J Nikkanen","year":"2016","unstructured":"Nikkanen, J. et al. Mitochondrial DNA replication defects disturb cellular dNTP pools and remodel one-carbon metabolism. Cell Metab. 23, 635\u2013648 (2016).","journal-title":"Cell Metab."},{"key":"1399_CR81","doi-asserted-by":"publisher","unstructured":"Mick, E. et al. Distinct mitochondrial defects trigger the integrated stress response depending on the metabolic state of the cell. Elife https:\/\/doi.org\/10.7554\/eLife.49178 (2020).","DOI":"10.7554\/eLife.49178"},{"key":"1399_CR82","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1097-2765(00)00028-9","volume":"6","author":"J Dong","year":"2000","unstructured":"Dong, J., Qiu, H., Garcia-Barrio, M., Anderson, J. & Hinnebusch, A. G. Uncharged tRNA activates GCN2 by displacing the protein kinase moiety from a bipartite tRNA-binding domain. Mol. Cell 6, 269\u2013279 (2000).","journal-title":"Mol. Cell"},{"key":"1399_CR83","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1074\/jbc.M707781200","volume":"283","author":"Y Watatani","year":"2008","unstructured":"Watatani, Y. et al. Stress-induced translation of ATF5 mRNA is regulated by the 5\u2032-untranslated region. J. Biol. Chem. 283, 2543\u20132553 (2008).","journal-title":"J. Biol. Chem."},{"key":"1399_CR84","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1152\/physiolgenomics.00263.2007","volume":"33","author":"JI Lee","year":"2008","unstructured":"Lee, J. I. et al. HepG2\/C3A cells respond to cysteine deprivation by induction of the amino acid deprivation\/integrated stress response pathway. Physiol. Genom. 33, 218\u2013229 (2008).","journal-title":"Physiol. Genom."},{"key":"1399_CR85","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","volume":"162","author":"K Birsoy","year":"2015","unstructured":"Birsoy, K. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540\u2013551 (2015).","journal-title":"Cell"},{"key":"1399_CR86","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson, S. et al. Variant interpretation using population databases: lessons from gnomAD. Hum. Mutat. 43, 1012\u20131030 (2022).","journal-title":"Hum. Mutat."},{"key":"1399_CR87","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 53, 1415\u20131424 (2021).","journal-title":"Nat. Genet."},{"key":"1399_CR88","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cmet.2023.03.001","volume":"35","author":"MC Costanzo","year":"2023","unstructured":"Costanzo, M. C. et al. The Type 2 Diabetes Knowledge Portal: an open access genetic resource dedicated to type 2 diabetes and related traits. Cell Metab. 35, 695\u2013710 e696 (2023).","journal-title":"Cell Metab."},{"key":"1399_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155329","volume":"137","author":"SC Larsson","year":"2022","unstructured":"Larsson, S. C., Michaelsson, K., Mola-Caminal, M., Hoijer, J. & Mantzoros, C. S. Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH. Metabolism 137, 155329 (2022).","journal-title":"Metabolism"},{"key":"1399_CR90","doi-asserted-by":"publisher","first-page":"e0202182","DOI":"10.1371\/journal.pone.0202182","volume":"13","author":"T Turner","year":"2018","unstructured":"Turner, T. et al. FGF21 increases water intake, urine output and blood pressure in rats. PLoS ONE 13, e0202182 (2018).","journal-title":"PLoS ONE"},{"key":"1399_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155616","volume":"145","author":"A Giontella","year":"2023","unstructured":"Giontella, A. et al. Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, proteome-wide and metabolome-wide association study. Metabolism 145, 155616 (2023).","journal-title":"Metabolism"},{"key":"1399_CR92","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.celrep.2018.03.070","volume":"23","author":"TM Frayling","year":"2018","unstructured":"Frayling, T. M. et al. A common allele in FGF21 associated with sugar intake is associated with body shape, lower total body-fat percentage, and higher blood pressure. Cell Rep. 23, 327\u2013336 (2018).","journal-title":"Cell Rep."},{"key":"1399_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30187-w","volume":"13","author":"S May-Wilson","year":"2022","unstructured":"May-Wilson, S. et al. Large-scale GWAS of food liking reveals genetic determinants and genetic correlations with distinct neurophysiological traits. Nat. Commun. 13, 2743 (2022).","journal-title":"Nat. Commun."},{"key":"1399_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1160440","volume":"14","author":"K Liang","year":"2023","unstructured":"Liang, K. Mitochondrial CPT1A: insights into structure, function, and basis for drug development. Front Pharm. 14, 1160440 (2023).","journal-title":"Front Pharm."},{"key":"1399_CR95","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1194\/jlr.R025882","volume":"53","author":"RA Srivastava","year":"2012","unstructured":"Srivastava, R. A. et al. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases. J. Lipid Res. 53, 2490\u20132514 (2012).","journal-title":"J. Lipid Res."},{"key":"1399_CR96","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1210\/clinem\/dgab686","volume":"107","author":"R Yang","year":"2022","unstructured":"Yang, R., Xu, A. & Kharitonenkov, A. Another kid on the block: long-acting FGF21 analogue to treat dyslipidemia and fatty liver. J. Clin. Endocrinol. Metab. 107, e417\u2013e419 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1399_CR97","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz9890","volume":"6","author":"CA Gilroy","year":"2020","unstructured":"Gilroy, C. A. et al. Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia. Sci. Adv. 6, eaaz9890 (2020).","journal-title":"Sci. Adv."},{"key":"1399_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12948","volume":"7","author":"SA Trammell","year":"2016","unstructured":"Trammell, S. A. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016).","journal-title":"Nat. Commun."},{"key":"1399_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/srep26933","volume":"6","author":"SA Trammell","year":"2016","unstructured":"Trammell, S. A. et al. Nicotinamide riboside opposes type 2 diabetes and neuropathy in mice. Sci. Rep. 6, 26933 (2016).","journal-title":"Sci. Rep."},{"key":"1399_CR100","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"1399_CR101","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"1399_CR102","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1399_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).","journal-title":"Genome Biol."},{"key":"1399_CR104","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"1399_CR105","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288\u20134297 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1399_CR106","doi-asserted-by":"publisher","unstructured":"Trammell, S. A. & Brenner, C. Targeted, LCMS-based metabolomics for quantitative measurement of NAD(+) metabolites. Comput. Struct. Biotechnol. J. https:\/\/doi.org\/10.5936\/csbj.201301012 (2013).","DOI":"10.5936\/csbj.201301012"},{"key":"1399_CR107","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1432-1033.1969.tb00696.x","volume":"10","author":"MA Sillero","year":"1969","unstructured":"Sillero, M. A., Sillero, A. & Sols, A. Enzymes involved in fructose metabolism in liver and the glyceraldehyde metabolic crossroads. Eur. J. Biochem. 10, 345\u2013350 (1969).","journal-title":"Eur. J. Biochem."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01399-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01399-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01399-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:05:48Z","timestamp":1763737548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01399-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":107,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["1399"],"URL":"https:\/\/doi.org\/10.1038\/s42255-025-01399-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.27.630525","asserted-by":"object"}]},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.B. is the coinventor of US provisional patent application 63\/739,033 for G3P-releasing prodrugs as FGF21-inducing compounds. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}